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Drug addiction is a serious worldwide problem with strong genetic and environmental influences. Different
technologies have revealed a variety of genes and pathways underlying addiction; however, each individual
technology can be biased and incomplete. We integrated 2,343 items of evidence from peer-reviewed publications
between 1976 and 2006 linking genes and chromosome regions to addiction by single-gene strategies, microrray,
proteomics, or genetic studies. We identified 1,500 human addiction-related genes and developed KARG (http://karg.
cbi.pku.edu.cn), the first molecular database for addiction-related genes with extensive annotations and a friendly
Web interface. We then performed a meta-analysis of 396 genes that were supported by two or more independent
items of evidence to identify 18 molecular pathways that were statistically significantly enriched, covering both
upstream signaling events and downstream effects. Five molecular pathways significantly enriched for all four
different types of addictive drugs were identified as common pathways which may underlie shared rewarding and
addictive actions, including two new ones, GnRH signaling pathway and gap junction. We connected the common
pathways into a hypothetical common molecular network for addiction. We observed that fast and slow positive
feedback loops were interlinked through CAMKII, which may provide clues to explain some of the irreversible features
of addiction.
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Introduction
Drug addiction, deﬁned as ‘‘the loss of control over drug
use, or the compulsive seeking and taking of drugs despite
adverse consequences,’’ has become one of the most serious
problems in the world [1]. It has been estimated that genetic
factors contribute to 40%–60% of the vulnerability to drug
addiction, and environmental factors provide the remainder
[2]. What are the genes and pathways underlying addiction? Is
there a common molecular network underlying addiction to
different abusive substances? Is there any network property
that may explain the long-lived and often irreversible
molecular and structural changes after addiction? These are
all important questions that need to be answered in order to
understand and control drug addiction.
Knowing the genes and vulnerable chromosome regions
that are related to addiction is an important ﬁrst step. Over
the past three decades, a number of technologies have been
used to generate such candidate genes or vulnerable
chromosome regions. For example, in hypothesis-driven
studies, genes in different brain regions were selectively
expressed, downregulated, or knocked out in animal models
of addiction [3]. Recent high-throughput expression-proﬁling
technologies such as microarray and proteomics analyses
identiﬁed candidate genes and proteins whose expression
level changed signiﬁcantly among different states in addic-
tion [4,5]. Finally, genetic studies such as animal Quantitative
Trait Locus (QTL) studies, genetic linkage studies, and
population association studies identiﬁed chromosomal re-
gions that may contribute to vulnerability to addiction [6–8].
However, as addiction involves a wide range of genes and
complicated mechanisms, any individual technology platform
or study may be limited or biased [3,9–14]. There is a need to
combine data across technology platforms and studies that
may complement one another [3,15,16]. The resultant gene
list, preferably in a database form with additional functional
information, would be a valuable resource for the commun-
ity. Systematic and statistical analysis of the genes and the
underlying pathways may provide a more complete picture of
the molecular mechanism underlying drug addiction.
Although different addictive drugs have disparate pharma-
cological effects, there are also similarities after acute and
chronic exposure such as acute rewarding and negative
emotional symptoms upon drug withdrawal [17]. Recently it
was asked ‘‘Is there a common molecular pathway for
addiction?’’ because elucidation of common molecular path-
ways underlying shared rewarding and addictive actions may
help the development of effective treatments for a wide range
of addictive disorders [17]. Several individual pathways have
been proposed as common pathways [17]; however, they have
not been studied systematically and statistically.
Key behavioral abnormalities associated with addiction are
long-lived with stable and irreversible molecular and struc-
tural changes in the brain, implying a ‘‘molecular and
structural switch’’ from controlled drug intake to compulsive
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addiction may involve positive feedback loops that were
known to make continuous processes discontinuous and
reversible processes irreversible [19]. Once a common
molecular network for addiction is constructed, we can look
for the existence of positive feedback loops in the network
and study the coupling between the loops. It may provide
clues to explain the network behaviour and the addiction
process.
Results
Most Comprehensive Collection and Database of
Addiction-Related Genes to Date
As currently the information is scattered in literature, we
retrieved and reviewed more than 1,000 peer-reviewed
publications from between 1976 and 2006 linking genes and
chromosome regions to addiction. In total, we collected 2,343
items of evidence linking 1,500 human genes to addiction.
The detailed statistics is shown in Figure 1 and Table S1. A
Knowledgebase of Addiction-Related Genes (KARG) is made
publicly available at http://karg.cbi.pku.edu.cn. A description
of the database statistics is given in Table S1, and the
functional annotation ﬁelds are listed in Table S2. Two
screenshots of the database user interface are shown in
Figures S1 and S2. The interface supports browsing of the
genes by chromosome or pathways, advanced text search by
gene ID, organism, type of addictive substance, technology
platform, protein domain, and/or PUBMED ID, and sequence
search by BLAST similarity [20]. All data, database schema,
and MySQL commands are freely available for download at
http://karg.cbi.pku.edu.cn/download.php.
Statistically Significantly Enriched Pathways in Addiction-
Related Genes
We analyzed in detail 396 genes that were supported by two
or more independent items of evidence. We found that 18
pathways were statistically signiﬁcantly enriched in addic-
tion-related genes compared to the whole genome as back-
ground, including both metabolic and signalling pathways
(Table 1). These pathways could be clustered into two
categories: (i) upstream events of drug addiction including
crosstalk among MAPK signaling, insulin signalling, and
calcium signalling, which share properties with long-term
potentiation; and (ii) downstream effects including regulation
of glycolysis metabolism, regulation of the actin cytoskeleton,
and apoptosis, which share components with a list of
neurodegenerative disorders such as Huntington disease
and amyotrophic lateral sclerosis. Gene Ontology enrichment
analysis conﬁrmed the ﬁndings (see details in Text S1 and
Table S3).
Common Molecular Pathways for Drug Addiction
Because we collected metadata about each item of evidence
linking genes to addiction, in particular the nature of the
addictive substance, we could ask next what are the pathways
underlying addiction to each type of substance, and what are
the common pathways among them. We identiﬁed ﬁve
pathways shared by all four addictive substances (Table 2).
Three of the pathways had been linked to addictive behaviors
in previous studies and were statistically conﬁrmed here. For
example, ‘‘long-term potentiation’’ h a db e e nl i n k e dt o
addiction-induced adaptations in glutamatergic transmission
and synaptic plasticity [21]. In particular, a core component
of this pathway, CAMKII, had been reported to regulate
neurite extension and synapse formation through regulation
of the actin cytoskeleton [22], providing possible explanations
for morphological changes triggered by addictive drugs [17].
This pathway was also considered a key molecular circuit
underling the memory system, highlighting the possible
shared mechanisms between drug addiction and the learning
and memory system [23]. ‘‘MAPK signaling pathway’’ is
another example, as previous studies had suggested its roles
in regulating synaptic plasticity related to long-lasting
changes in both memory function and addictive properties
[24].
More interestingly, two other common pathways identiﬁed
here had not been directly linked to addiction. ‘‘GnRH
signaling pathway’’ was reported to activate gene expression
and secretion of gonadotropins and regulate stress pathways
in the hypothalamo-pituitary gonadal axis and mammalian
reproduction [25]. It is reasonable to hypothesize that the
pathway may also be involved in the regulation and control of
certain emotional behaviors in addiction such as stress-
induced drug-seeking. Another common pathway identiﬁed
in our study, ‘‘Gap junctions’’, can be regulated directly by
three addiction-related kinases in the ‘‘long-term potentia-
tion’’ pathway, PKA, PKC, and ERK. Since gap junctions are
not only an important type of connection for neuroglial cells
but also the most prevalent group of electrical synapses in the
brain [26], this regulation may imply potential modiﬁcation
of cell communication in addiction. It would be interesting to
investigate the roles of these pathways in future experimental
studies.
A pathway is in itself a subjective concept, whereas the real
systems are dynamic and include wide-ranging crosstalk
among functional modules. Connecting the common path-
ways with additional protein–protein interaction data, we
constructed a hypothetical common molecular network for
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Author Summary
Drug addiction has become one of the most serious problems in the
world. It has been estimated that genetic factors contribute to 40%–
60% of the vulnerability to drug addiction, and environmental
factors provide the remainder. What are the genes and pathways
underlying addiction? Is there a common molecular network
underlying addiction to different abusive substances? Is there any
network property that may explain the long-lived and often
irreversible molecular and structural changes after addiction? These
important questions were traditionally studied experimentally. The
explosion of genomic and proteomic data in recent years both
enabled and necessitated bioinformatic studies of addiction. We
integrated data derived from multiple technology platforms and
collected 2,343 items of evidence linking genes and chromosome
regions to addiction. We identified 18 statistically significantly
enriched molecular pathways. In particular, five of them were
common for four types of addictive drugs, which may underlie
shared rewarding and addictive actions, including two new ones,
GnRH signaling pathway and gap junction. We connected the
common pathways into a hypothetical common molecular network
for addiction. We observed that fast and slow positive feedback
loops were interlinked through CAMKII, which may provide clues to
explain some of the irreversible features of addiction.
Genes and Pathways Underlying Addictiondrug addiction, shown in Figure 2 (see details in Text S2 and
Figure S3).
Positive Feedback Loops in the Network
From the common pathway network we identiﬁed four
positive feedback loops, shown in Figure 2. We further
observed that they interlinked with each other through
CAMKII (Figure 2). Two of these positive feedback loops
involved signal transduction and would be considered ‘‘fast’’
loops, whereas the other two loops involved transcription and
translation and would be considered ‘‘slow’’ loops. It had
been reported in a dozen systems, such as budding yeast
polarization and Xenopus oocyte maturation, that coupled fast
and slow positive feedback loops could create a switch that
was inducible and resistant to noise and played key roles in
discontinuous and irreversible biological process, features
characteristic of addiction [27–29]. It was also known that
activation of CAMKII played key roles in the development
and maintenance of addiction states [30,31]. Disruption of
dendritic CaMKII translation impaired the stabilization of
synaptic plasticity and memory consolidation [32,33]. These
evidences, taken together, suggested that the fast and slow
positive feedback loops interlinked through CAMKII may be
essential for the development and consolidation of addiction
and may provide a systems-level explanation for some of the
characteristics of addictive disorders.
Discussion
The addiction-related genes, (common) pathways, and
networks were traditionally studied experimentally. The
explosion of genomic and proteomic data in recent years
both enabled and necessitated bioinformatic studies of
addiction. Integration of data from multiple sources could
remove biases of any single technology platform, and
statistical and network analysis of the integrated data could
Figure 1. Pipeline for Collection of Data and Identification of (Common) Molecular Networks for Drug Addiction
Strategies used to study the genetic and environmental influences underlying addiction were divided into two types. Candidate gene-based strategies
identified a list of genes related to addiction, including candidate genes identified in classical animal models, significantly differentially expressed genes
identified in microarray or proteomics assays, and OMIM annotations. Strategies focused on genetic factors identified a list of addiction-vulnerable
regions through animal QTL studies, genetic linkage studies, and population association studies. We integrated these datasets and obtained a list of
human addiction-related genes. This dataset was then divided into four subsets based on addictive drugs, and analyzed using KOBAS, a statistical
method to identify enriched molecular pathways. Molecular pathways enriched for all subsets were considered to be common pathways for drug
addiction, which were further connected to construct a common molecular network underlying different types of addiction.
doi:10.1371/journal.pcbi.0040002.g001
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Genes and Pathways Underlying Addictionuncover high-level patterns not detectable in any individual
study. For instance, our analysis revealed not only many
pathways already implicated in addiction [34–38], but also
new ones such as GnRH signaling pathway and gap junction,
as well as the coupled positive feedback loops through
CAMKII. They could serve as interesting hypotheses for
further experimental testing.
The collection of addiction-related genes and pathways in
KARG, the ﬁrst bioinformatic database for addiction, is the
most comprehensive to date. However, as new technologies
continue to be developed and used, more and more genes will
be linked to addiction. In 2004, a paper asked why proteomics
technology was not introduced to the ﬁeld of drug addiction
[5]; since then eleven studies have identiﬁed about 100
differentially expressed proteins in drug addiction. Tilling-
array technology, another new strategy for whole-genome
identiﬁcation of transcription factors binding sites, has been
used to identify targets of CREB, an important transcription
factor implicated in drug addiction [39]. In addition, as 100 K
and 500 K SNP arrays have been introduced recently, whole
genome association studies will also identify more closely
packed and unbiased hypothesis-free vulnerable positions
[40]. We will continue to integrate new data and update the
gene list and molecular pathways toward a better under-
standing of drug addiction.
Materials and Methods
Collection of addiction-related genes. The data collection pipeline
is summarized in Figure 1. The data and knowledge linking genes and
chromosome regions to addiction were extracted from reviewing
more than 1,000 peer-reviewed publications from between 1976 and
2006. This list of publications, available on KARG Web site at http://
karg.cbi.pku.edu.cn/pmid.php, included recent review papers on
addiction selected from results of PUBMED query ‘(addiction OR
‘‘drug abuse") AND review’ as well as research papers selected from
PUBMED query ‘(addiction OR ‘‘drug abuse") AND (gene OR
microarray OR proteomics OR QTL OR ‘‘population association’’
OR ‘‘genetic linkage’’)’. The data spanned multiple technology
platforms including classical hypothesis-testing of single genes,
identiﬁcation of signiﬁcantly differentially expressed genes in micro-
array experiments, identiﬁcation of signiﬁcantly differentially ex-
pressed proteins in proteomics assays, identiﬁcation of addiction-
vulnerable chromosome regions in animal QTL studies, genetic
linkage studies, population association studies, and OMIM annota-
tions [41]. From each publication we collected the genes, proteins, or
chromosome regions linked to addiction, as well as metadata such as
species, nature of the addictive substance, studied brain regions,
technology platforms, and experimental parameters. For candidate
genes or chromosomal regions identiﬁed in mouse or rat, we mapped
them to human genes through ortholog mapping by Homologene or
syntenic mapping, respectively [41]. For chromosome regions
identiﬁed in genetic studies, we identiﬁed candidate genes when at
least one positive marker lay (i) within the gene or (ii) in 39 or 59
ﬂanking sequences that were contained on a block of high restricted
haplotype diversity along with exon sequences from the same gene
[8]. In total, we collected 2,343 items of evidence linking 1,500 human
genes to addiction. Among them 396 genes were supported by two or
more items of evidence (see full list in Table S4). This more reliable
subset was used in subsequent analysis.
Identiﬁcation of pathways statistically signiﬁcantly enriched in
addiction-related genes We used the FASTA sequences of the 396
human addiction-related genes as input to the KOBAS software,
using all known genes in the human genome as background [42,43].
KOBAS had been shown to lead to experimentally validated pathways
[44]. It maps the input sequences to similar sequences in known
pathways in the KEGG database [45] (as determined by BLAST
similarity search with evaluated cut off e-values ,1e-5, rank  10),
and then groups the input genes by pathways. Because some pathways
are naturally large, they may appear highly represented in a random
selection of genes or gene products. To resolve this, KOBAS selects
the pathways that are more likely to be biologically meaningful by
calculating the statistical signiﬁcance of each pathway in the input set
of genes or gene products against all pathways in the whole genome
as background. For each pathway that occurs in the input genes,
Table 1. Significantly Enriched KEGG Pathways for Addiction-
Related Genes
Pathways p-Value Q-Value
Long-term depression 2.1E-07 1.1E-05
Gap junction 1.5E-07 1.1E-05
Long-term potentiation 3.5E-06 7.2E-05
Neuroactive ligand-receptor interaction 2.1E-06 7.2E-05
MAPK signaling pathway 3.1E-06 7.2E-05
GnRH signaling pathway 8.5E-06 1.5E-04
Calcium signaling pathway 4.8E-04 7.0E-03
Colorectal cancer 6.5E-04 8.3E-03
Pores ion channels 2.1E-03 0.02
VEGF signaling pathway 3.2E-03 0.03
Glycolysis/Gluconeogenesis 3.8E-03 0.03
Protein folding and associated processing 3.8E-03 0.03
Focal adhesion 4.4E-03 0.03
Insulin signaling pathway 4.9E-03 0.03
Parkinson disease 6.3E-03 0.04
Fc epsilon RI signaling pathway 6.9E-03 0.04
Type II diabetes mellitus 7.7E-03 0.05
Progesterone-mediated oocyte maturation 9.1E-03 0.05
doi:10.1371/journal.pcbi.0040002.t001
Table 2. Common Molecular Pathways Identified in Different Types of Drug Addiction
Addictive Drugs Cocaine Alcohol Opioids Nicotine
Neuroactive ligand-receptor interaction p-Value 5.39E-05 3.24E-02 2.68E-03 7.79E-03
Q-Value 1.8E-04 0.05 0.01 0.04
Long-term potentiation p -Value 3.21E-08 8.28E-03 1.05E-02 8.84E-03
Q-Value 2.8E-07 0.03 0.03 0.04
GnRH signaling pathway p -Value 2.84E-05 3.93E-04 4.67E-03 1.72E-02
Q-Value 1.2E-04 3.6E-03 0.02 0.05
MAPK signaling pathway p -Value 1.28E-04 2.97E-04 7.34E-05 1.10E-02
Q-Value 3.7E-04 3.6E-03 5.2E-04 0.04
Gap junctions p -Value 1.93E-08 3.11E-03 3.30E-03 5.85E-03
Q-Value 2.8E-07 0.01 0.01 0.03
doi:10.1371/journal.pcbi.0040002.t002
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Genes and Pathways Underlying AddictionKOBAS counts the total number of genes in the input that are
involved in the pathway, named m, and the total number of genes in
the whole genome that are involved in the same pathway, named M. If
input has n genes and the whole genome has N genes, the p-value of
the pathway is calculated using a hypergeometric distribution:
p ¼ 1  
X m 1
i¼0
ðM
i
ÞðN   M
n   i
Þ
ð
N
n Þ
KOBAS then performs FDR correction [42] to adjust for multiple
testing. Pathways with FDR-corrected Q-value , 0.05 were considered
statistically signiﬁcantly enriched in the input set of addiction-related
genes.
Identiﬁcation of ‘‘common’’ molecular pathways and network. For
each of the four addictive substances, cocaine, opiate, alcohol and
nicotine, we input its list of related genes to KOBAS to identify the
statistically signiﬁcantly enriched pathways. Molecular pathways that
were identiﬁed as signiﬁcantly enriched for all four addictive
substances were selected as common pathways for drug addiction.
We constructed a large molecular network of addiction-related
genes with the nodes being the gene products and the links extracted
from the KEGG database, the Biomolecular Interaction Network
Database (BIND), and Human Interactome Map (HIMAP) [46]. The
network was analyzed and visualized by Medusa [47]. We selected a
more biologically meaningful sub-network representing only the
common pathways identiﬁed above.
Development of a database for addiction-related genes. We
developed a database with MySQL relational schema. Cross-reference
to key external databases were included to integrate functional
information about the genes, such as gene annotation [41], Gene
Ontology annotation [48], interacting proteins [46], and functional
domain annotations [49]. In addition, a link was given to the original
literature reference in the NCBI PubMed database [41]. We
implemented a Web-based user interface of the database using PHP
and queries of the database using PHP/SQL query script.
Supporting Information
Figure S1. Chromosome View of Addiction-Related Genes and
Genetic Vulnerability Points for Addiction
In window (A),þand indicate addiction-related genes on the plus or
the minus chain, respectively, while ‘*’ labels addiction-vulnerable
points identiﬁed in population association studies. Clicking blueþor
  in the (A) window links to detailed descriptions of that gene (B),
including basic information, evidence implicating it in addiction and
various functional annotations. Clicking the red stars links to a
detailed description of this genetic vulnerable point (C), including
evidence for implication in addiction and functional annotations of
Figure 2. Hypothetical Common Molecular Network for Drug Addiction
The network was constructed manually based on the common pathways identified in our study and protein interaction data. Addiction-related genes
were represented as white boxes while neurotransmitters and secondary massagers were highlighted in purple. The common pathways are highlighted
in green boxes. Related functional modules such as ‘‘regulation of cytoskeleton’’, ‘‘regulation of cell cycle’’, ‘‘regulation of gap junction’’, and ‘‘gene
expression and secretion of gonadotropins’’ were highlighted in carmine boxes. Several positive feedback loops were identified in this network. Fast
positive feedback loops were highlighted in red lines and slow ones were highlighted in blue lines.
doi:10.1371/journal.pcbi.0040002.g002
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Genes and Pathways Underlying Addictionthis point (such as the nearest genes and possible effects on these
genes).
Found at doi:10.1371/journal.pcbi.0040002.sg001 (1.4 MB TIF).
Figure S2. Pathway View of Addiction-Related Genes
In window (A), statistically signiﬁcant pathways are listed with p-
values and Q-values. Clicking pathway names link to (B), pages
showing interactive charts for that pathway, derived from KEGG. In
the chart, addiction-related genes are highlighted in red. Detailed
descriptions of each gene can be retrieved when clicking genes in the
chart.
Found at doi:10.1371/journal.pcbi.0040002.sg002 (932 KB TIF).
Figure S3. Protein Interaction Networks of Addiction-Related Genes
On the basis of KEGG data and protein interaction data deposited in
BIND and HIMAP, we developed a hypothetical addiction-related
molecular network using the whole set of human addiction-related
genes (A). The network was analyzed and visualized by Medusa.
Upstream events, including crosstalk among the MAPK pathway,
insulin signaling, and calcium signaling, are highlighted in the yellow
square, while events implicated in cell development and communi-
cation are marked in red circles (including focal adhesion, adhesion
junction, tight junction, gap junction, and axon guidance). Genes
implicated in neurodegeneration are highlighted as diamonds. It is
clear that genes in upstream events and downstream events have an
interface, which are further manually separated and visualized (B).
Genes represented in this interface are highlighted in purple. Genes
represented in upstream events or downstream events, which have
direct interaction with interface genes, are highlighted in red or blue,
respectively. Especially, several genes having more than three
interactions with interface genes are highlighted in green. This
subnetwork may provide a screenshot to explain the relationship
between upstream kinase signaling pathways and downstream events
such as cytoskeletal modiﬁcation.
Found at doi:10.1371/journal.pcbi.0040002.sg003 (6.2 MB TIF).
Table S1. Statistics of the Database
Found at doi:10.1371/journal.pcbi.0040002.st001 (34 KB DOC).
Table S2. Contents of Database Entries
Found at doi:10.1371/journal.pcbi.0040002.st002 (36 KB DOC).
Table S3. Signiﬁcantly Enriched Gene Ontology Terms in Addiction-
Related Genes
Found at doi:10.1371/journal.pcbi.0040002.st003 (73 KB DOC).
Table S4. Addiction-Related Genes for Four Addictive Substances
Found at doi:10.1371/journal.pcbi.0040002.st004 (713 KB DOC).
Text S1. Gene Ontology Annotation and Functional Enrichment
Analysis
Found at doi:10.1371/journal.pcbi.0040002.sd001 (25 KB DOC).
Text S2. Molecular Interaction Networks Underlying Drug Addiction
Found at doi:10.1371/journal.pcbi.0040002.sd002 (35 KB DOC).
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